Previous comprehensive meta-analyses examining PD-L1 expression in patients with NSCLC and its prognostic implications have demonstrated that elevated tumor PD-L1 expression is associated with reduced survival durations (77–79). Here, CD274 is linked to non-small cell lung carcinoma.